Gurnet Point Capital
North America, Massachusetts, United States, Cambridge
Description
Gurnet Point Capital is a private equity firm that invests in de-risked life sciences companies
Investor Profile
Gurnet Point Capital has backed more than 11 startups, with 0 new investments in the last 12 months alone. The firm has led 8 rounds, about 73% of its total and boasts 0 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series A, Series Unknown, Private Equity rounds (top funding stages).
- Majority of deals are located in United States, Israel, Switzerland.
- Strong thematic focus on Health Care, Biotechnology, Medical.
Stage Focus
- Series A (36%)
- Series Unknown (27%)
- Private Equity (18%)
- Series C (9%)
- Series B (9%)
Country Focus
- United States (82%)
- Israel (9%)
- Switzerland (9%)
Industry Focus
- Health Care
- Biotechnology
- Medical
- Pharmaceutical
- Baby
- Consumer Goods
- Wellness
- Clinical Trials
- Therapeutics
- Biopharma
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
Who does Gurnet Point Capital frequently co-invest with?
Which angels does Gurnet Point Capital often collaborate with?
What are some of recent deals done by Gurnet Point Capital?
Find More Investors Like Gurnet Point Capital
Discover similar investors in our database and build your perfect investor list.
Need help with your fundraising strategy?Read our fundraising guides
